Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | AMGN | VRTX | REGN | GILD |
| Company | Urovant Sciences Ltd | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 16.23 | 311.03 | 472.14 | 1,027.47 | 66.62 |
| High | 16.24 | 313.41 | 476.57 | 1,040.05 | 66.93 |
| Low | 16.21 | 308.57 | 471.76 | 1,025.80 | 66.01 |
| Last | 16.24 | 310.65 | 473.64 | 1,032.33 | 66.70 |
| Change | +0.01 | +1.27 | +3.36 | +8.24 | +0.11 |
| % Change | +0.06% | +0.41% | +0.71% | +0.80% | +0.17% |
| Volume | 1,739,000 | 620,867 | 406,017 | 186,023 | 2,520,303 |
| 20-Day Average Volume | 143,510 | 2,333,913 | 1,222,396 | 467,893 | 9,013,379 |
| Previous Close | 16.23 | 309.38 | 470.28 | 1,024.09 | 66.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 307.99 | 475.17 | 1,037.70 | 66.78 |
| 20-Day Raw Stochastic | 87.10% | 49.33% | 46.95% | 46.17% | 41.07% |
| 20-Day Relative Strength | 65.56% | 55.42% | 59.90% | 56.25% | 48.66% |
| Weighted Alpha | +6.45 | +36.19 | +41.86 | +45.13 | -13.71 |
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | 80% Buy | 56% Sell |
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | 80% Buy | 56% Sell |
| Last Month's Opinion | 96% Buy | 72% Buy | 88% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | -1.02% since 06/27/24 | +0.34% since 06/27/24 | -1.67% since 06/27/24 | -3.26% since 06/27/24 |
| Low | 16.20 on 03/24/21 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 16.25 on 03/25/21 | 319.00 on 07/01/24 | 478.96 on 07/01/24 | 1,069.69 on 07/01/24 | 69.99 on 07/01/24 |
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | +1.02% since 06/05/24 | -1.85% since 06/05/24 | +2.73% since 06/05/24 | +4.23% since 06/05/24 |
| Low | 16.10 on 03/02/21 | 295.30 on 06/13/24 | 463.23 on 06/20/24 | 992.22 on 06/10/24 | 62.69 on 06/18/24 |
| High | 16.26 on 03/19/21 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | +15.02% since 04/05/24 | +16.59% since 04/05/24 | +9.61% since 04/05/24 | -4.30% since 04/05/24 |
| Low | 16.03 on 12/30/20 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 16.26 on 03/19/21 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | +2.48% since 01/05/24 | +13.83% since 01/05/24 | +13.15% since 01/05/24 | -20.08% since 01/05/24 |
| Low | 7.15 on 11/02/20 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 16.26 on 03/19/21 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 165,962,256 | 121,357,168 | 112,840,368 | 82,961,352 |
| Shares Outstanding, K | 32,743 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -146,750,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -46,800,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 2.35 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 02/11/21 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.68 | 31.46 | 28.15 | 16.97 |